Director
AstraZeneca -, Massachusetts, United States
Diane Ramsden is a Director and ADME group leader within AstraZeneca Oncology. Along with leading the ADME group, within Boston, she is also responsible for representing drug metabolism and pharmacokinetics (DMPK) on program teams. Prior to joining AstraZeneca she was an Associate Director within GI and NS Development in Takeda. She also spent two years at Alnylam, the industry leader in harnessing RNA interference, and 16 years at Boehringer Ingelheim where she served as a DMPK project representative and hepatocyte lab head. Her research interests include the application of in vitro and in vivo models towards developing a mechanistic understanding of the disposition of novel therapeutics.
Disclosure information not submitted.
Tuesday, February 8, 2022
3:00 PM – 4:00 PM